Abstract:Background: The research on the role of the World Trade Organization in solving the vaccine patent waiver problem related to the 2019 coronavirus disease pandemic will address each issue one by one. Seeing the waiver applications that were made from the end of 2020 to 2022, it is necessary to further study the legal basis and enforcement of patents. Coupled with its relation to public health and equality for the global world to achieve. This study aims to provide an understanding of the role of the WTO in the patent waiver application process and the continuity of current and future patent law enforcement. Method: This research is a normative research with a descriptive method that will explain with the aim of obtaining a description of the events of the patent waiver application. The data that has been obtained will be analysed qualitatively. Conclusions will be obtained from various descriptive data collected from primary and secondary sources that have been analysed. In this regard, this research will be descriptive-analytical in nature which will reveal existing regulations and their implementation. Findings: The results of this study are that the WTO has carried out its roles and functions in accordance with applicable international legal instruments. However, this research emphasises further on the principles of the WTO itself which emphasises justice for developing and less developed countries on the other words called Special and Differential Treatment of Developing Countries (SDT). Coupled with the existence of the Doha Declaration which should emphasise that public health should take precedence over intellectual property rights, including patents. Conclusion: Regarding the WTO's role in resolving vaccine patent issues during the COVID-19 pandemic, it can be concluded that the actions taken by the WTO, including its internal bodies and councils, adhere to applicable legal principles and the TRIPs Agreement. However, the decisions must fully align with the WTO's principles, particularly the Special and Differential Treatment of Developing Countries (SDT). Novelty/Originality of this study: This study analyzes the role of the WTO in resolving vaccine patent issues during the COVID-19 pandemic, focusing on the SDT principles and the Doha Declaration. It reveals the gap between international law and global health needs, offering a framework for balancing intellectual property rights with public health needs.

Intellectual Property, COVID-19 Vaccines and Equity: A Public Health and Human Rights Critique

Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine

Protection of intellectual property and human rights during health emergencies: an assessment of the patent waiver proposal

Exclusivity in Times of a Public Necessity: Balance of Interests in South Asia’s Compulsory Licensing Regime

Reconciling the global public health interest with intellectual property protection through the waiver of certain provisions of the WTO TRIPS Agreement

Pandemics, intellectual property and 'our economy': A worldview analysis of Canada's role in compromising global access to COVID-19 vaccines

COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform

Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity

Temporary Waiver of Patent Rights in Public Health Emergencies: Inadequacy of Provisions during the COVID-19 Crisis

Intellectual Property Rights and Access in Crisis

Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO

Access to COVID-19 Vaccines: A New Global Approach

COVID-19 and Global Distributive Justice: 'Health Diplomacy' of India and South Africa for the TRIPS waiver

TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness

The legal basis fot the application of patent waiver settlements in the covid-19 pandemic

Global Health Jurisprudence: COVID-19 Pandemic and Pharmaceutical Patents

Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap

Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements

TRIPS and the Primacy of Public Health

An Empirical Study on Growth of IPR during Covid-19 Pandemic